)
Biomea Fusion (BMEA) investor relations material
Biomea Fusion AGM 2026 summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Opening remarks and agenda
Interim CEO called the meeting to order, welcomed shareholders, and introduced directors and officers.
Meeting held in accordance with bylaws and Delaware law; formal business outlined in the notice and proxy statement.
Independent auditors and legal counsel were present for the meeting.
Corporate governance
Record of stockholders as of April 13, 2026, was available for inspection prior to the meeting.
Louis D. Larson appointed as Inspector of Election to oversee and tabulate voting results.
Quorum confirmed with a majority of shares represented in person or by proxy.
Board and executive committee updates
Two nominees, Rainer M. Erdtmann and Eric Aguiar, MD, were nominated for Class II Director positions for a three-year term.
No stockholder nominations for directors were received; nominations declared closed.
- Phase II diabetes and obesity trials advance, with key data expected in the next 12 months.BMEA
Jefferies Global Healthcare Conference 20264 Jun 2026 - Icovamenib and BMF-650 show promise for durable diabetes and obesity treatment breakthroughs.BMEA
Corporate presentation4 Jun 2026 - Icovamenib and BMF-650 advance in trials, targeting diabetes and obesity with novel mechanisms.BMEA
H.C. Wainwright 4th Annual BioConnect Investor Conference19 May 2026 - Clinical progress and narrowed losses extend cash runway into Q1 2027, but more funding is needed.BMEA
Q1 202612 May 2026 - Icovamenib offers durable glycemic control and beta cell regeneration in diabetes.BMEA
Status update5 May 2026 - Icovamenib increased C-peptide by 52% at 12 weeks and preserved beta cell function at 1 year.BMEA
Study result29 Apr 2026 - Oral therapies icovamenib and BMF-650 advance toward major diabetes and obesity milestones.BMEA
Corporate presentation27 Apr 2026 - Virtual meeting to elect directors and ratify auditor, with strong governance and oversight.BMEA
Proxy filing27 Apr 2026 - Icovamenib may transform diabetes care by restoring beta cell function and delaying insulin use.BMEA
Fireside chat30 Mar 2026
Next Biomea Fusion earnings date
Next Biomea Fusion earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Explore our global coverage
)
)